<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sun Q</submitter><funding>First Hospital of Jilin University</funding><funding>Project of Jilin Provincial Department of science and technology</funding><pagination>7619</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9655109</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>27(21)</volume><pubmed_abstract>A simple sample preprocessing method was developed for the quantitative determination of amantadine (AMT) in human plasma by liquid chromatography-tandem mass spectrometry cubed (LC-MS&lt;sup>3&lt;/sup>). The LC-MS&lt;sup>3&lt;/sup> system comprised a Shimadzu Exion LC-20AD HPLC pump coupled with a QTRAP 5500 mass spectrometer. First, the plasma samples were pretreated using acetonitrile as the extracting solution to precipitate protein. Next, amantadine and amantadine-d&lt;sub>15&lt;/sub> (AMT-d&lt;sub>15&lt;/sub>) were separated on an Agilent Poroshell 120 SB-C18 column (4.6 mm × 50 mm, 2.7 μm) using isocratic elution with solvent A (70% 0.1% formic acid) and solvent B (30% acetonitrile) at a flow rate of 0.8 mL/min. The total run time for each sample was 3 min. The system used triple-stage fragmentation transi</pubmed_abstract><journal>Molecules (Basel, Switzerland)</journal><pubmed_title>Comparison of LC-MS&lt;sup>3&lt;/sup> and LC-MRM Methods for Quantifying Amantadine and Its Application in Therapeutic Amantadine Monitoring in Human Plasma.</pubmed_title><pmcid>PMC9655109</pmcid><funding_grant_id>20200404167YY</funding_grant_id><funding_grant_id>JDYY2021-A0009</funding_grant_id><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Cao H</pubmed_authors><pubmed_authors>Sun Q</pubmed_authors><pubmed_authors>Huang J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Comparison of LC-MS&lt;sup>3&lt;/sup> and LC-MRM Methods for Quantifying Amantadine and Its Application in Therapeutic Amantadine Monitoring in Human Plasma.</name><description>A simple sample preprocessing method was developed for the quantitative determination of amantadine (AMT) in human plasma by liquid chromatography-tandem mass spectrometry cubed (LC-MS&lt;sup>3&lt;/sup>). The LC-MS&lt;sup>3&lt;/sup> system comprised a Shimadzu Exion LC-20AD HPLC pump coupled with a QTRAP 5500 mass spectrometer. First, the plasma samples were pretreated using acetonitrile as the extracting solution to precipitate protein. Next, amantadine and amantadine-d&lt;sub>15&lt;/sub> (AMT-d&lt;sub>15&lt;/sub>) were separated on an Agilent Poroshell 120 SB-C18 column (4.6 mm × 50 mm, 2.7 μm) using isocratic elution with solvent A (70% 0.1% formic acid) and solvent B (30% acetonitrile) at a flow rate of 0.8 mL/min. The total run time for each sample was 3 min. The system used triple-stage fragmentation transi</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-04-25T23:36:37.709Z</modification><creation>2025-04-06T09:23:49.302Z</creation></dates><accession>S-EPMC9655109</accession><cross_references><pubmed>36364446</pubmed><doi>10.3390/molecules27217619</doi></cross_references></HashMap>